Community post
Qunbin
Multiple Myeloma Discussion • July 18, 2025
Update on Anselamimab Phase III Trial
AI-generated title
Update on CARES Phase III clinical programme of anselamimab in light chain amyloidosis (CAEL-101)
https://www.astrazeneca.com/media-centre/press-releases/2025/update-on-anselamimab-in-al-amyloidosis.html
No comments yet.